Efficacy and safety of oral iron supplementation with liposomal iron in non-dialysis chronic kidney disease patients with iron deficiency

被引：0
|
作者：
Cesarano, Davide [1 ]
Campilongo, Giorgia [2 ]
Papadia, Federica [2 ]
De Marco, Antonia [2 ]
Borrelli, Silvio [1 ]
Cirillo, Pietro [2 ]
Minutolo, Roberto [1 ]
机构：
[1] Univ Campania Luigi Vanvitelli, Naples, Italy
[2] Univ Bari Aldo Moro, Bari, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
2264
引用
收藏
页码：I2325 / I2326
页数：2
相关论文
共 50 条
  • [11] Prevalence of iron deficiency in patients with non-dialysis chronic kidney disease: The CARENFER national, multicentre, observational study
    Choukroun, Gabriel
    Kazes, Isabelle
    Dantal, Jacques
    Vabret, Elsa
    Couzi, Lionel
    Le Meur, Yannick
    Trochu, Jean-Noel
    Cacoub, Patrice
    Les, Pour
    NEPHROLOGIE & THERAPEUTIQUE, 2022, 18 (03): : 195 - 201
  • [12] A COMPARATIVE HEALTHCARE COST ANALYSIS OF PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY/ANEMIA TREATED WITH ORAL OR INTRAVENOUS IRON USING A GERMAN CLAIMS DATABASE
    Borchert, Kathrin
    Krinke, Kim-Sarah
    Wachter, Sandra
    Gavata-Steiger, Simona
    Haas, Jennifer
    Braun, Sebastian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 477 - 477
  • [13] INTRAVENOUS FERRIC CARBOXYMALTOSE VS ORAL IRON IN ANAEMIC PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY: RESULTS OF THE RANDOMISED FIND-CKD STUDY
    Macdougall, I. D.
    Bock, A.
    Carrera, F.
    Eckardt, K-U
    Gaillard, C.
    Van Wyck, D.
    Roubert, B.
    Nolen, J.
    Roger, S. D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 21 - 21
  • [14] Retrospective Assessment of Total Cost of Care in Non-Dialysis Dependent Chronic Kidney Disease Patients Receiving Parenteral Iron Therapy for Iron Deficiency Anemia
    Wang, Kevin
    Kwong, Jackie
    Wang, Peng
    Boccia, Ralph, V
    BLOOD, 2022, 140 : 4998 - 4999
  • [15] COST-EFFECTIVE MANAGEMENT OF IRON DEFICIENCY AMONG PATIENTS WITH ANEMIA AND NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
    Perkins, Robert
    Bucaloiu, Ion D.
    Bailey, Matthew
    Shah, Nirav
    Pitcavage, James
    Schultz, Michael
    Hartle, James E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A77 - A77
  • [16] IRON ISOMALTOSIDE 1000 (MONOFER®) COMPARED TO ORAL IRON SULPHATE IN EUROPEAN PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD)
    Kalra, Philip A.
    Bhandari, Sunil
    Thomsen, Lars L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [17] ORAL IRON-BASED PHOSPHATE BINDER, FERRIC CITRATE, INCREASES IRON MEASURES IN DIALYSIS-DEPENDENT AND NON-DIALYSIS DEPENDENT PATIENTS WITH CHRONIC KIDNEY DISEASE
    Fishbane, S.
    Loram, L.
    Ganz, T.
    HAEMATOLOGICA, 2015, 100 : 598 - 599
  • [18] Iron-repletive and clinical efficacy of oral iron supplementation in anemic chronic heart failure patients with iron deficiency
    Amosova, K.
    Tsaralunga, V.
    Krychynska, IIryna
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 150 - 151
  • [19] Comparing the efficacy of intravenous iron and oral iron in nondialysis patients with chronic kidney disease
    Walter H Hörl
    Nature Clinical Practice Nephrology, 2008, 4 : 530 - 531
  • [20] Comparing the efficacy of intravenous iron and oral iron in nondialysis patients with chronic kidney disease
    Hoerl, Walter H.
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (10): : 530 - 531
12345